Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: A contributor to endothelial cell glycocalyx dysfunction

FASEB Journal

Volumn 28, Issue 11, 2014, Pages 4686-4699

  Ramnath, Raina ^a   Foster, Rebecca R ^a   Qiu, Yan ^a   Cope, George ^a   Butler, Matthew J ^a   Salmon, Andrew H ^a   Mathieson, Peter W ^a   Coward, Richard J ^a   Welsh, Gavin I ^a   Satchell, Simon C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Heparan sulfate; Microvascular permeability

Indexed keywords

ALBUMIN; BATIMASTAT; GELATINASE B; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARAN SULFATE; MESSENGER RNA; SMALL INTERFERING RNA; SYNDECAN 4; TUMOR NECROSIS FACTOR ALPHA; MMP9 PROTEIN, HUMAN; PROTEOGLYCAN; TUMOR NECROSIS FACTOR;

ARTICLE; CELL DISRUPTION; CELL SURFACE; CONTROLLED STUDY; CULTURE MEDIUM; DOT HYBRIDIZATION; ENDOTHELIUM CELL; GENE SILENCING; GLYCOCALYX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MONOLAYER CULTURE; PROTEIN MODIFICATION; PROTEIN SHEDDING; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REDUCTION; UPREGULATION; WESTERN BLOTTING; CELL CULTURE; CELL MEMBRANE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GLYCOCALYX; HUMANS; MATRIX METALLOPROTEINASE 9; PROTEOGLYCANS; SYNDECAN-4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84912081314     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-252221     Document Type: Article

References (58)

1. Satchell, S. (2013) The role of the glomerular endothelium in albumin handling. Nat. Rev. Nephrol. 9, 717-725
2. Weinbaum, S., Tarbell, J. M., and Damiano, E. R. (2007) The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 9, 121-167
3. Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A., and oude Egbrink, M. G. (2007) The endothelial glycocalyx: composition, functions, and visualization. Pflügers Arch. 454, 345-359
4. Bass, M. D., Morgan, M. R., and Humphries, M. J. (2009) Syndecans shed their reputation as inert molecules. Sci. Signal 2, pe18
5. Couchman, J. R. (2010) Transmembrane signaling proteoglycans. Annu. Rev. Cell Dev. Biol. 26, 89-114
6. Manon-Jensen, T., Itoh, Y., and Couchman, J. R. (2010) Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J. 277, 3876-3889
7. Multhaupt, H. A., Yoneda, A., Whiteford, J. R., Oh, E. S., Lee, W., and Couchman, J. R. (2009) Syndecan signaling: when, where and why? J. Physiol. Pharmacol. 60(Suppl. 4), 31-38
8. Chappell, D., Jacob, M., Hofmann-Kiefer, K., Rehm, M., Welsch, U., Conzen, P., and Becker, B. F. (2009) Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/ reperfusion. Cardiovasc. Res. 83, 388-396
9. Ostrowski, S. R., Pedersen, S. H., Jensen, J. S., Mogelvang, R., and Johansson, P. I. (2013) Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit. Care. 17, R32
10. Levick, J. R., and Michel, C. C. (2010) Microvascular fluid exchange and the revised Starling principle. Cardiovasc. Res. 87, 198-210
11. Salmon, A. H., and Satchell, S. C. (2012) Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J. Pathol. 226, 562-574
12. Haraldsson, B., Nystrom, J., and Deen, W. M. (2008) Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88, 451-487
13. Bjornson, A., Moses, J., Ingemansson, A., Haraldsson, B., and Sorensson, J. (2005) Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification. Am. J. Physiol. Renal Physiol. 288, F748-F756
14. Singh, A., Friden, V., Dasgupta, I., Foster, R. R., Welsh, G. I., Tooke, J. E., Haraldsson, B., Mathieson, P. W., and Satchell, S. C. (2011) High glucose causes dysfunction of the human glomerular endothelial glycocalyx. Am. J. Physiol. Renal Physiol. 300, F40-F48
15. Singh, A., Satchell, S. C., Neal, C. R., McKenzie, E. A., Tooke, J. E., and Mathieson, P. W. (2007) Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J. Am. Soc. Nephrol. 18, 2885-2893
16. Foster, R. R., Armstrong, L., Baker, S., Wong, D. W. L., Wylie, E. E., Ramnath, R., Jenkins, R., Singh, A., Steadman, R., Welsh, G. I., Mathieson, P. W., and Satchell, S. C. (2013) Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro. Am. J. Pathol. 183, 604-616
17. Kim, C. W., Goldberger, O. A., Gallo, R. L., and Bernfield, M. (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development- specific patterns. Mol. Biol. Cell 5, 797-805
18. Pyke, C., Kristensen, P., Ostergaard, P. B., Oturai, P. S., and Romer, J. (1997) Proteoglycan expression in the normal rat kidney. Nephron 77, 461-470
19. Chen, S., Wassenhove-McCarthy, D., Yamaguchi, Y., Holzman, L., van Kuppevelt, T. H., Orr, A. W., Funk, S., Woods, A., and McCarthy, K. (2010) Podocytes require the engagement of cell surface heparan sulfate proteoglycans for adhesion to extracellular matrices. Kidney Int. 78, 1088-1099
20. Adembri, C., Sgambati, E., Vitali, L., Selmi, V., Margheri, M., Tani, A., Bonaccini, L., Nosi, D., Caldini, A. L., Formigli, L., and De Gaudio, A. R. (2011) Sepsis induces albuminuria and alterations in the glomerular filtration barrier: a morphofunctional study in the rat. Crit. Care 15, R277
21. Rops, A. L., Gotte, M., Baselmans, M. H., van den Hoven, M. J., Steenbergen, E. J., Lensen, J. F., Wijnhoven, T. J., Cevikbas, F., van den Heuvel, L. P., van Kuppevelt, T. H., Berden, J. H., and van der Vlag, J. (2007) Syndecan-1 deficiency aggravates antiglomerular basement membrane nephritis. Kidney Int. 72, 1204-1215
22. Satoh, M., Kobayashi, S., Kuwabara, A., Tomita, N., Sasaki, T., and Kashihara, N. (2010) In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats. Microcirculation 17, 103-112
23. Jeansson, M., Granqvist, A. B., Nystrom, J. S., and Haraldsson, B. (2006) Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia 49, 2200-2209
24. Nieuwdorp, M., Mooij, H. L., Kroon, J., Atasever, B., Spaan, J. A., Ince, C., Holleman, F., Diamant, M., Heine, R. J., Hoekstra, J. B., Kastelein, J. J., Stroes, E. S., and Vink, H. (2006) Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 55, 1127-1132
25. Broekhuizen, L. N., Lemkes, B. A., Mooij, H. L., Meuwese, M. C., Verberne, H., Holleman, F., Schlingemann, R. O., Nieuwdorp, M., Stroes, E. S., and Vink, H. (2010) Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 53, 2646-2655
26. Satchell, S. C., and Tooke, J. E. (2008) What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 51, 714-725
27. Jensen, J. S., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., and Borch-Johnsen, K. (2000) Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35, 898-903
28. Schalkwijk, C. G., and Stehouwer, C. D. (2005) Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci. (Lond.) 109, 143-159
29. Singh, A., Ramnath, R. D., Foster, R. R., Wylie, E. C., Friden, V., Dasgupta, I., Haraldsson, B., Welsh, G. I., Mathieson, P. W., and Satchell, S. C. (2013) Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One 8, e55852
30. Navarro-Gonzalez, J. F., and Mora-Fernandez, C. (2008) The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 19, 433-442
31. Navarro, J. F., Milena, F. J., Mora, C., Leon, C., Claverie, F., Flores, C., and Garcia, J. (2005) Tumor necrosis factor-α gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Kidney Int. Suppl. 99, S98-S102
32. Friedl, J., Puhlmann, M., Bartlett, D. L., Libutti, S. K., Turner, E. N., Gnant, M. F., and Alexander, H. R. (2002) Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100, 1334-1339
33. Henry, C. B., and Duling, B. R. (2000) TNF-α increases entry of macromolecules into luminal endothelial cell glycocalyx. Am. J. Physiol. Heart Circ. Physiol. 279, H2815-H2823
34. Chappell, D., Hofmann-Kiefer, K., Jacob, M., Rehm, M., Briegel, J., Welsch, U., Conzen, P., and Becker, B. F. (2008) TNF-α induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Res. Cardiol. 104, 78-89
35. Satchell, S. C., Tasman, C. H., Singh, A., Ni, L., Geelen, J., von Ruhland, C. J., O'Hare, M. J., Saleem, M. A., van den Heuvel, L. P., and Mathieson, P. W. (2006) Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 69, 1633-1640
36. Satchell, S. C., Anderson, K. L., and Mathieson, P. W. (2004) Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J. Am. Soc. Nephrol. 15, 566-574
37. Bjornson Granqvist, A., Ebefors, K., Saleem, M. A., Mathieson, P. W., Haraldsson, B., and Nystrom, J. S. (2006) Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome. Am. J. Physiol. Renal Physiol. 291, F722-F730
38. Lassalle, P., Molet, S., Janin, A., Heyden, J. V., Tavernier, J., Fiers, W., Devos, R., and Tonnel, A. B. (1996) ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J. Biol. Chem. 271, 20458-20464
39. Sato, T., Gotoh, M., Kiyohara, K., Akashima, T., Iwasaki, H., Kameyama, A., Mochizuki, H., Yada, T., Inaba, N., Togayachi, A., Kudo, T., Asada, M., Watanabe, H., Imamura, T., Kimata, K., and Narimatsu, H. (2003) Differential roles of two N-acetylgalactosaminyltransferases, CSGalNAcT-1, and a novel enzyme, CSGalNAcT-2. Initiation and elongation in synthesis of chondroitin sulfate. J. Biol. Chem. 278, 3063-3071
40. Strand, M. E., Herum, K. M., Rana, Z. A., Skrbic, B., Askevold, E. T., Dahl, C. P., Vistnes, M., Hasic, A., Kvaloy, H., Sjaastad, I., Carlson, C. R., Tonnessen, T., Gullestad, L., Christensen, G., and Lunde, I. G. (2013) Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart. FEBS J. 280, 2228-2247
41. Tan, X., Khalil, N., Tesarik, C., Vanapalli, K., Yaputra, V., Alkhouri, H., Oliver, B. G., Armour, C. L., and Hughes, J. M. (2012) Th1 cytokine-induced syndecan-4 shedding by airway smooth muscle cells is dependent on mitogen-activated protein kinases. Am. J. Physiol. Lung Cell. Mol. Physiol. 302, L700-L710
42. Zhang, Y., Pasparakis, M., Kollias, G., and Simons, M. (1999) Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-alpha. J. Biol. Chem. 274, 14786-14790
43. Pruessmeyer, J., Martin, C., Hess, F. M., Schwarz, N., Schmidt, S., Kogel, T., Hoettecke, N., Schmidt, B., Sechi, A., Uhlig, S., and Ludwig, A. (2010) A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan- 1 and -4 by lung epithelial cells. J. Biol. Chem. 285, 555-564
44. Fan, Q., Shike, T., Shigihara, T., Tanimoto, M., Gohda, T., Makita, Y., Wang, L. N., Horikoshi, S., and Tomino, Y. (2003) Gene expression profile in diabetic KK/Ta mice. Kidney Int. 64, 1978-1985
45. Ramani, V. C., Pruett, P. S., Thompson, C. A., DeLucas, L. D., and Sanderson, R. D. (2012) Heparan sulfate chains of syndecan- 1 regulate ectodomain shedding. J. Biol. Chem. 287, 9952-9961
46. Gil, N., Goldberg, R., Neuman, T., Garsen, M., Zcharia, E., Rubinstein, A. M., van Kuppevelt, T., Meirovitz, A., Pisano, C., Li, J. P., van der Vlag, J., Vlodavsky, I., and Elkin, M. (2012) Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes 61, 208-216
47. Fernandez-Real, J. M., Vendrell, J., Garcia, I., Ricart, W., and Valles, M. (2012) Structural damage in diabetic nephropathy is associated with TNF-α system activity. Acta Diabetol. 49, 301-305
48. Navarro-Gonzalez, J. F., Jarque, A., Muros, M., Mora, C., and Garcia, J. (2009) Tumor necrosis factor-α as a therapeutic target for diabetic nephropathy. Cytokine Growth Factor Rev. 20, 165-173
49. Gharagozlian, S., Svennevig, K., Bangstad, H. J., Winberg, J. O., and Kolset, S. O. (2009) Matrix metalloproteinases in subjects with type 1 diabetes. BMC Clin. Pathol. 9, 7
50. Nair, S., Phillips, A. O., Norton, N., Spurlock, G., Williams, H. J., Craig, K. J., Williams, J. D., Williams, N. M., and Bowen, T. (2008) Further evidence for the association of MMP9 with nephropathy in type 2 diabetes and application of DNA pooling technology to candidate gene screening. J. Nephrol. 21, 400-405
51. Brule, S., Charnaux, N., Sutton, A., Ledoux, D., Chaigneau, T., Saffar, L., and Gattegno, L. (2006) The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. Glycobiology 16, 488-501
52. Gambaro, G., Cavazzana, A. O., Luzi, P., Piccoli, A., Borsatti, A., Crepaldi, G., Marchi, E., Venturini, A. P., and Baggio, B. (1992) Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int. 42, 285-291
53. Tamsma, J. T., van der Woude, F. J., and Lemkes, H. H. (1996) Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy. Nephrol. Dial. Transplant. 11, 182-185
54. Sulikowska, B., Olejniczak, H., Muszynska, M., Odrowaz- Sypniewska, G., Gaddi, A., Savini, C., Cicero, A. F., Laghi, L., and Manitius, J. (2006) Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients. Am. J. Nephrol. 26, 621-628
55. Diabetic Albuminuria Vessel Tunisia Study Investigators D, Blouza, S., Dakhli, S., Abid, H., Aissaoui, M., Ardhaoui, I., Ben Abdallah, N., Ben Brahim, S., Ben Ghorbel, I., Ben Salem, N., Beji, S., Chamakhi, S., Derbel, A., Derouiche, F., Djait, F., Doghri, T., Fourti, Y., Gharbi, F., Jellouli, K., Jellazi, N., Kamoun, K., Khedher, A., Letaief, A., Limam, R., Mekaouer, A., Miledi, R., Nagati, K., Naouar, M., Sellem, S., Tarzi, H., Turki, S., Zidi, B., and Achour, A. (2010) Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy. J. Nephrol. 23, 415-424
56. Masola, V., Onisto, M., Zaza, G., Lupo, A., and Gambaro, G. (2012) A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition. J. Transl. Med. 10, 213
57. Karon, J., Polubinska, A., Antoniewicz, A. A., Suminska-Jasinska, K., and Breborowicz, A. (2007) Anti-inflammatory effect of sulodexide during acute peritonitis in rats. Blood Purif. 25, 510-514
58. Satchell, S. C. (2012) The glomerular endothelium emerges as a key player in diabetic nephropathy. Kidney Int. 82, 949-951